Grifols shares have been struggling since a short seller last year criticized its accounting practices and accused the drug maker of bad governance. Later in 2024,
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.
